Regulation of visfatin by microbial and biomechanical signals in PDL cells

Clinical Oral Investigations

Volumn 18, Issue 1, 2014, Pages 171-178

  Nogueira, Andressa Vilas Boas ^a,b   Nokhbehsaim, Marjan ^b   Eick, Sigrun ^c   Bourauel, Christoph ^b   Jäger, Andreas ^b   Jepsen, Søren ^b   Cirelli, Joni Augusto ^a   Deschner, James ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Biomechanics; Forces; Fusobacterium nucleatum; Periodontal ligament; Tension; Visfatin

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

BIOMECHANICS; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FUSOBACTERIUM NUCLEATUM; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PERIODONTAL LIGAMENT; REAL TIME POLYMERASE CHAIN REACTION;

BIOMECHANICAL PHENOMENA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUSOBACTERIUM NUCLEATUM; HUMANS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PERIODONTAL LIGAMENT; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84891560005     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-013-0935-1     Document Type: Article

References (51)

1. Pihlstrom BL, Michalowicz BS, Johnson NW (2005) Periodontal diseases. Lancet 366: 1809-1820.
2. Sbordone L, Bortolaia C (2003) Oral microbial biofilms and plaque-related diseases: microbial communities and their role in the shift from oral health to disease. Clin Oral Investig 7: 181-188.
3. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K (2007) Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 13(Suppl 4): 3-10.
4. Naveh GR, Lev-Tov Chattah N, Zaslansky P, Shahar R, Weiner S (2012) Tooth-PDL-bone complex: response to compressive loads encountered during mastication-a review. Arch Oral Biol 57(12): 1575-1584.
5. McCulloch CA, Lekic P, McKee MD (2000) Role of physical forces in regulating the form and function of the periodontal ligament. Periodontol 24: 56-72.
6. Harrel SK, Nunn ME (2001) The effect of occlusal discrepancies on periodontitis. II. Relationship of occlusal treatment to the progression of periodontal disease. J Periodontol 72: 495-505.
7. Nunn ME, Harrel SK (2001) The effect of occlusal discrepancies on periodontitis. I. Relationship of initial occlusal discrepancies to initial clinical parameters. J Periodontol 72: 485-494.
8. Wennström JL, Stokland BL, Nyman S, Thilander B (1993) Periodontal tissue response to orthodontic movement of teeth with infrabony pockets. Am J Orthod Dentofacial Orthop 103: 313-319.
9. Bildt MM, Bloemen M, Kuijpers-Jagtman AM, Von den Hoff JW (2009) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in gingival crevicular fluid during orthodontic tooth movement. Eur J Orthod 31: 529-535.
10. Ren Y, Vissink A (2008) Cytokines in crevicular fluid and orthodontic tooth movement. Eur J Oral Sci 116: 89-97.
11. Goto KT, Kajiya H, Nemoto T, Tsutsumi T, Tsuzuki T, Sato H, Okabe K (2011) Hyperocclusion stimulates osteoclastogenesis via CCL2 expression. J Dent Res 90: 793-798.
12. Chaffee BW, Weston SJ (2010) Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol 81: 1708-1724.
13. Johnson AR, Justin Milner J, Makowski L (2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249: 218-238.
14. Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93: 64-73.
15. Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F, Gualillo O (2011) Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors 37: 413-420.
16. Inadera H (2008) The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci 5: 248-262.
17. Preshaw PM, Foster N, Taylor JJ (2007) Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontol 2000 45: 138-157.
18. Kanda N, Hau CS, Tada Y, Tatsuta A, Sato S, Watanabe S (2011) Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes. Endocrinology 152: 3155-3164.
19. Lee WJ, Wu CS, Lin H, Lee IT, Wu CM, Tseng JJ, Chou MM, Sheu WH (2009) Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappaB pathway. Int J Obes (Lond) 33: 465-472.
20. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178: 1748-1758.
21. Taşkesen D, Kirel B, Us T (2012) Serum visfatin levels, adiposity and glucose metabolism in obese adolescents. J Clin Res Pediatr Endocrinol 4: 76-81.
22. Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ (2011) Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 27: 515-527.
23. Zhang LQ, Heruth DP, Ye SQ (2011) Nicotinamide phosphoribosyltransferase in Human Diseases. J Bioanal Biomed 3: 13-25.
24. Saddi-Rosa P, Oliveira CS, Giuffrida FM, Reis AF (2010) Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syndr 2: 21.
25. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ (2006) Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91: 295-299.
26. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B (2006) Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91: 1578-1581.
27. Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54: 2911-2916.
28. Pradeep AR, Raghavendra NM, Prasad MV, Kathariya R, Patel SP, Sharma A (2011) Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease. J Periodontol 82: 1314-1319.
29. Pradeep AR, Raghavendra NM, Sharma A, Patel SP, Raju A, Kathariya R, Rao NS, Naik SB (2012) Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus. J Periodontol 83: 629-634.
30. Raghavendra NM, Pradeep AR, Kathariya R, Sharma A, Rao NS, Naik SB (2012) Effect of non-surgical periodontal therapy on gingival crevicular fluid and serum visfatin concentration in periodontal health and disease. Dis Markers 32: 383-388.
31. Nokhbehsaim M, Deschner B, Winter J, Reimann S, Bourauel C, Jepsen S, Jäger A, Deschner J (2010) Contribution of orthodontic load to inflammation-mediated periodontal destruction. J Orofac Orthop 71: 390-402.
32. Nokhbehsaim M, Deschner B, Bourauel C, Reimann S, Winter J, Rath B, Jäger A, Jepsen S, Deschner J (2011) Interactions of enamel matrix derivative and biomechanical loading in periodontal regenerative healing. J Periodontol 82: 1725-1734.
33. Nokhbehsaim M, Deschner B, Winter J, Bourauel C, Rath B, Jäger A, Jepsen S, Deschner J (2011) Interactions of regenerative, inflammatory and biomechanical signals on bone morphogenetic protein-2 in periodontal ligament cells. J Periodontal Res 46: 374-381.
34. Nokhbehsaim M, Deschner B, Winter J, Bourauel C, Jäger A, Jepsen S, Deschner J (2012) Anti-inflammatory effects of EMD in the presence of biomechanical loading and interleukin-1β in vitro. Clin Oral Investig 16: 275-283.
35. Lee KJ, Shin YA, Lee KY, Jun TW, Song W (2010) Aerobic exercise training-induced decrease in plasma visfatin and insulin resistance in obese female adolescents. Int J Sport Nutr Exerc Metab 20: 275-281.
36. Dahl TB, Holm S, Aukrust P, Halvorsen B (2012) Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology. Annu Rev Nutr 32: 229-243.
37. Li Y, Zhang Y, Dorweiler B, Cui D, Wang T, Woo CW, Brunkan CS, Wolberger C, Imai S, Tabas I (2008) Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem 283: 34833-34843.
38. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113: 1318-1327.
39. Signat B, Roques C, Poulet P, Duffaut D (2011) Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol 13: 25-36.
40. He J, Huang W, Pan Z, Cui H, Qi G, Zhou X, Chen H (2011) Quantitative analysis of microbiota in saliva, supragingival, and subgingival plaque of Chinese adults with chronic periodontitis. Clin Oral Investig 16(6): 1579-8.
41. Dabija-Wolter G, Cimpan MR, Costea DE, Johannessen AC, Sørnes S, Neppelberg E, Al-Haroni M, Skaug N, Bakken V (2009) Fusobacterium nucleatum enters normal human oral fibroblasts in vitro. J Periodontol 80: 1174-1183.
42. Ji S, Shin JE, Kim YS, Oh JE, Min BM, Choi Y (2009) Toll-like receptor 2 and NALP2 mediate induction of human beta-defensins by Fusobacterium nucleatum in gingival epithelial cells. Infect Immun 77: 1044-1052.
43. Han YW, Shi W, Huang GT, Kinder Haake S, Park NH, Kuramitsu H, Genco RJ (2000) Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 68: 3140-3146.
44. Saito A, Inagaki S, Kimizuka R, Okuda K, Hosaka Y, Nakagawa T, Ishihara K (2008) Fusobacterium nucleatum enhances invasion of human gingival epithelial and aortic endothelial cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol 54: 349-355.
45. Agarwal S, Long P, Seyedain A, Piesco N, Shree A, Gassner R (2003) A central role for the nuclear factor-kappaB pathway in anti-inflammatory and proinflammatory actions of mechanical strain. FASEB J 17: 899-901.
46. Long P, Hu J, Piesco N, Buckley M, Agarwal S (2001) Low magnitude of tensile strain inhibits IL-1beta-dependent induction of pro-inflammatory cytokines and induces synthesis of IL-10 in human periodontal ligament cells in vitro. J Dent Res 80: 1416-1420.
47. Doyle SL, O'Neill LA (2006) Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72: 1102-1113.
48. Yoshimura A, Kaneko T, Kato Y, Golenbock DT, Hara Y (2002) Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4. Infect Immun 70: 218-225.
49. Eick S, Straube A, Guentsch A, Pfister W, Jentsch H (2011) Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment. Diagn Microbiol Infect Dis 69: 12-20.
50. Ziegler A, Keilig L, Kawarizadeh A, Jäger A, Bourauel C (2005) Numerical simulation of the biomechanical behaviour of multi-rooted teeth. Eur J Orthod 27: 333-339.
51. Toms SR, Dakin GJ, Lemons JE, Eberhardt AW (2002) Quasi-linear viscoelastic behavior of the human periodontal ligament. J Biomech 35: 1411-1415.